Assessing the impact of COVID-19 passes and mandates on disease transmission, vaccination intention, and uptake: a scoping review

Author:

Natalia Yessika Adelwin,Delporte Margaux,De Witte Dries,Beutels Philippe,Dewatripont Mathias,Molenberghs Geert

Abstract

Abstract Purpose Policymakers have struggled to maintain SARS-CoV-2 transmission at levels that are manageable to contain the COVID-19 disease burden while enabling a maximum of societal and economic activities. One of the tools that have been used to facilitate this is the so-called “COVID-19 pass”. We aimed to document current evidence on the effectiveness of COVID-19 passes, distinguishing their indirect effects by improving vaccination intention and uptake from their direct effects on COVID-19 transmission measured by the incidence of cases, hospitalizations, and deaths. Methods We performed a scoping review on the scientific literature of the proposed topic covering the period January 2021 to September 2022, in accordance with the PRISMA-ScR guidelines for scoping reviews. Results Out of a yield of 4,693 publications, 45 studies from multiple countries were retained for full-text review. The results suggest that implementing COVID-19 passes tends to reduce the incidence of cases, hospitalizations, and deaths due to COVID-19. The use of COVID-19 passes was also shown to improve overall vaccination uptake and intention, but not in people who hold strong anti-COVID-19 vaccine beliefs. Conclusion The evidence from the literature we reviewed tends to indicate positive direct and indirect effects from the use of COVID-19 passes. A major limitation to establishing this firmly is the entanglement of individual effects of multiple measures being implemented simultaneously.

Funder

European Union - ESCAPE project

Publisher

Springer Science and Business Media LLC

Subject

Public Health, Environmental and Occupational Health

Reference74 articles.

1. Kamin-Friedman S, Peled Raz M. Lessons from Israel’s COVID-19 Green Pass program. Israel J Health Policy Res. 2021;10(1):61. https://doi.org/10.1186/s13584-021-00496-4.

2. The Local Denmark. Denmark launches new corona passport: here’s what you need to know about ‘Coronapas’ app. https://www.thelocal.dk/20210528/denmark-launches-new-corona-passport-heres-what-you-need-to-know-about-coronapas-app/. Accessed 1 Aug 2022.

3. European Parliament and Council. Regulation (EU) 2021/953 of the European Parliament and of the Council of 14 June 2021 on a framework for the issuance, verification and acceptance of interoperable COVID-19 vaccination, test, and recovery certificates (EU Digital COVID Certificate) to facilitate free movement during the COVID-19 pandemic (Text with EEA relevance). https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A32021R0953. Accessed 2 Aug 2022.

4. Rijksinstituut voor Volksgezondheid en Milieu (RIVM). Tijdlijn van coronamaatregelen 2021. https://www.rivm.nl/gedragsonderzoek/tijdlijn-van-coronamaatregelen-2021. Accessed 1 Aug 2022.

5. Gazzetta Ufficiale Della Repubblica Italiana. DECRETO-LEGGE 23 luglio 2021, n. 105. Misure urgenti per fronteggiare l’emergenza epidemiologica da COVID-19 e per l’esercizio in sicurezza di attivita’ sociali ed economiche. https://www.gazzettaufficiale.it/eli/id/2021/07/23/21G00117/sg. Accessed 2 Aug 2022.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3